A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice

CARES (Contrast EchocArdiography REgistry for Safety Surveillance): A Prospective, Phase IV, Open-Label, Nonrandomized, Multicenter, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice

The purpose of this registry study is to gather safety information on the current clinical use of and the safety of DEFINITY®

Inclusion criteria

• Patients who, in the investigator's opinion, require DEFINITY® echocardiography due to suboptimal, unenhanced images.

Exclusion criteria

• Known hypersensitivity to perflutren, DEFINITY®, or other echo contrast agent.
• Prior SAE associated with perflutren, DEFINITY®, or administration of other echo contrast agent.